Breaking News

You are here » Indian-Commodity  :  Commodities  :  Copper Gets Back But Increase In Greenback, Euro Issues Cap Gains

10-May2011

Copper Gets Back But Increase In Greenback, Euro Issues Cap Gains

Copper rates rebounded on Monday soon after moving to the minimum stages in close to 5 month on Friday, as better than expected United states employment information enhanced trader feelings. However, more benefit possibilities for the reddish material rates were assigned by gratitude in American dollar after reduce or eliminate of Greece`s ranking to B from BB- by S&P, drawn the item rates further.

Copper commodities for July supply increased by 4.10 cents or 1% to stay at $4.0165 a pound on the Comex materials section of the NYME .Copper for 3 month shipping on the LME superior by $65 to $8,890 a tonne.

Related News

View all news

BT Cotton Seeds Businesses Targeting Earnings Of Rs 700 Crore This Season

BT Cotton seeds organizations are targeting earnings of Rs 700 cr this season as a result of a rise ......

Gold Challenges To Maintain Earlier Increases As The Problems In Europe Prolongs

Gold prices surrounded reduce on Monday because the euro solved their deficits in opposition to the ......

Copper Seems To Lengthen Uptrend As Dollar Recoils

Copper rates were able to lengthen the uptrend for 3rd instantly period on Monday, as traders proved......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......